Published in Women's Health Weekly, September 7th, 1998
The FDA is expected to make final decisions on both drugs by November 1998, but it typically follows its advisers' recommendations.
The drug, tamoxifen, made headlines earlier this year when the National Cancer Institute (NCI) declared it could help...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly